Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 18, 2024

BUY
$212.02 - $267.71 $636 - $803
3 New
3 $0
Q2 2021

Jul 19, 2021

SELL
$259.0 - $414.71 $42,735 - $68,427
-165 Closed
0 $0
Q1 2021

Apr 20, 2021

BUY
$242.95 - $284.63 $40,086 - $46,963
165 New
165 $46,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.1B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Piscataqua Savings Bank Portfolio

Follow Piscataqua Savings Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Piscataqua Savings Bank, based on Form 13F filings with the SEC.

News

Stay updated on Piscataqua Savings Bank with notifications on news.